Related Experiment Videos
Changes in neurotransmitters in multiple sclerosis
V P Barkhatova1, I A Zavalishin, L Sh Askarova
1Institute of Neurology, Russian Academy of Medical Sciences, Moscow.
Neuroscience and Behavioral Physiology
|October 8, 1998
Summary
Patients with multiple sclerosis show elevated neurotransmitter levels in cerebrospinal fluid and blood. These biochemical changes correlate with neurological symptoms and disease progression, suggesting a role in multiple sclerosis pathogenesis.
Area of Science:
- Neuroscience
- Biochemistry
- Immunology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- The exact pathogenesis of MS remains incompletely understood.
- Neurotransmitter imbalances may contribute to MS pathology.
Purpose of the Study:
- To investigate cerebrospinal fluid (CSF) and blood biochemical profiles in MS patients.
- To correlate biochemical findings with clinical symptoms and disease course.
- To explore the role of neurotransmitters in MS pathogenesis.
Main Methods:
- Analysis of CSF and blood samples from MS patients.
- Quantification of neurotransmitter and amino acid levels.
- Correlation analysis between biochemical data and clinical parameters.
Main Results:
- Elevated CSF noradrenaline, glutamate, and aspartate levels were observed.
- Increased blood glutamine, asparagine, and glycine levels were found.
- Significant associations between these biochemical markers and neurological symptoms/disease course were identified.
Conclusions:
- Neurotransmitter alterations are present in MS patients.
- These biochemical changes are linked to disease severity and progression.
- Neurotransmitters may play a crucial role in the neuroimmune mechanisms of MS.